Literature DB >> 2523955

Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania.

J O Hill1, M Awwad, R J North.   

Abstract

This study examined the capacity of BALB/c mice that had been depleted of T cell subpopulations to generate a protective immune response to Leishmania major. Thymectomized mice were depleted of either L3T4+ (CD4+) T lymphocytes, Ly2+ (CD8+) T lymphocytes, or both, by treatment with appropriate mAbs. It was found that susceptible mice were rendered resistant to Leishmania by an intravenous infusion of anti-L3T4 mAb. These mice generated an immune response that destroyed the parasite in the primary lesion and in visceral metastatic foci. CD4+ cell-depleted mice also acquired a capacity to mount a sustained delayed-type hypersensitivity (DTH) response to parasite antigens, indicating that DTH, per se, is not a disease-promoting mechanism in the susceptible murine host as has been suggested. Depleting BALB/c mice of CD8+, as well as CD4+ T cells, left them highly susceptible to Leishmania infection, thereby indicating that CD8+ lymphocytes are key protective cells. Our results can be interpreted as showing that the susceptibility of BALB/c mice is due to the generation of CD4+ cells that suppress either the generation or expression of CD8+ T cell-mediated antiLeishmania immunity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523955      PMCID: PMC2189324          DOI: 10.1084/jem.169.5.1819

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

Review 1.  Down-regulation of the antitumor immune response.

Authors:  R J North
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

2.  Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice.

Authors:  R G Titus; R Ceredig; J C Cerottini; J A Louis
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

3.  Immunoregulation of genetically controlled acquired responses to Leishmania donovani infection in mice: demonstration and characterization of suppressor T cells in noncure mice.

Authors:  J M Blackwell; O M Ulczak
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

4.  Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility.

Authors:  G F Mitchell; E Handman
Journal:  Aust J Exp Biol Med Sci       Date:  1983-02

5.  Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.

Authors:  D L Sacks; P A Scott; R Asofsky; F A Sher
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

6.  Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.

Authors:  G Milon; R G Titus; J C Cerottini; G Marchal; J A Louis
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

7.  A comparative study of different Leishmania tropica isolates from Iran: correlation between infectivity and cytochemical properties.

Authors:  A Ebrahimzadeh; T C Jones
Journal:  Am J Trop Med Hyg       Date:  1983-07       Impact factor: 2.345

8.  Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.

Authors:  F Y Liew; J G Howard; C Hale
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

9.  Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.

Authors:  M Awwad; R J North
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

10.  Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica.

Authors:  J G Howard; C Hale; F Y Liew
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  32 in total

1.  Reduced numbers of CD4+ suppressor cells with subsequent expansion of CD8+ protective T cells as an explanation for the paradoxical state of enhanced resistance to Leishmania in T-cell deficient BALB/c mice.

Authors:  J O Hill
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

Review 2.  Cutaneous leishmaniasis: a model for analysis of the immunoregulation by accessory cells.

Authors:  H Moll; U Ritter; S Flohé; K Erb; C Bauer; C Blank
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

3.  Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas.

Authors:  F Roch; M A Bach
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

4.  'Subthreshold stimulation' of allospecific delayed hypersensitivity by corneal allografts.

Authors:  J Y Niederkorn; E Mayhew
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

5.  Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection.

Authors:  D McMahon-Pratt; D Rodriguez; J R Rodriguez; Y Zhang; K Manson; C Bergman; L Rivas; J F Rodriguez; K L Lohman; N H Ruddle
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

6.  CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice.

Authors:  S J Parker; C W Roberts; J Alexander
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

7.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.

Authors:  F P Heinzel; M D Sadick; S S Mutha; R M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

Review 8.  Leishmaniases of the New World: current concepts and implications for future research.

Authors:  G Grimaldi; R B Tesh
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

9.  Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells.

Authors:  I Müller; P Kropf; R J Etges; J A Louis
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

10.  The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation.

Authors:  D L Tolson; A Jardim; L F Schnur; C Stebeck; C Tuckey; R P Beecroft; H S Teh; R W Olafson; T W Pearson
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.